Evidence map›Paper›PMID 28680583›Full record

ArticlePulmonary circulation2017

Enhanced inflammatory cell profiles in schistosomiasis-induced pulmonary vascular remodeling.

Zahara Ali, Djuro Kosanovic, Ewa Kolosionek, Ralph T Schermuly, Brian B Graham, Alistair Mathie, Ghazwan Butrous

Open access · hybridAbstract read
In one paragraph

Article in Pulmonary circulation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Early Activation of Lung CD8Pathogens & immunity · 2025
    Article
  2. Article
  3. Schistosome infection and its effect on pulmonary circulation.Global cardiology science & practice · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Zahara AliUniversity of Kent, Medway School of Pharmacy, Chatham, Kent, UK.
Djuro KosanovicUniversities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Giessen, Germany.
Ewa KolosionekUniversity of Kent, Medway School of Pharmacy, Chatham, Kent, UK.
Ralph T SchermulyUniversities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Giessen, Germany.
Brian B GrahamDepartment of Medicine, University of Colorado, Denver, CO, USA.
Alistair MathieUniversity of Kent, Medway School of Pharmacy, Chatham, Kent, UK.
Ghazwan ButrousUniversity of Kent, Medway School of Pharmacy, Chatham, Kent, UK.
Medway School of Pharmacy · GBUniversity of Kent · GBGerman Center for Lung Research · DEUniversities of Giessen and Marburg Lung Center · DEUniversity of Colorado Denver · US

Funding

Investigating paclitaxel treatment in a pre-clinical model of Schistosoma-pulmonary hypertensionR01HL135872 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Brian Barkley Graham · 2017 to 2026
$5.1M
Schistosomiasis Associated Pulmonary Arterial HypertensionK08HL105536 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI GRAHAM, BRIAN BARKLEY · 2011 to 2015
$653k
NHLBI NIH HHS K08 HL105536NHLBI NIH HHS R01 HL135872
6 · The paper itself

Abstract

Schistosomiasis (bilharzia) is a neglected parasitic disease caused by trematode flatworms of the genus

Indexed as

chemokinesinflammationinflammatory cellspulmonary vascular remodelingSchistosomiasis

Identifiers

PMID28680583
PMCPMC5448541
OpenAlexW2563672812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.